资讯
Huo Xue Tong Luo Capsule (HXTL) has been clinically used to treat osteonecrosis of the femoral head, osteoporosis, and other bone and joint diseases with promising effects.
Steminent Biotherapeutics Inc. is set to present Stemchymal®, its lead investigational therapy, at the World Orphan Drug ...
Swedish golf legend Jesper Parnevik, known for his flair and fitness, opens up about stem cell therapy, longevity, and why ...
Steminent Biotherapeutics specializes in developing innovative stem cell-based therapeutics that offer new hope for patients ...
Universiti Kebangsaan Malaysia (UKM) created history when it became the first institution in the country to successfully ...
Mesenchymal stem cells (MSCs) have long been recognized for their potential in cancer therapy. However, the effectiveness of MSCs in cancer treatment has been hampered by their limited tumor-homing ...
Wa'el Hashad Wa'el Hashad, CEO, Longeveron MIAMI, April 22, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a ...
With 26.6% of the European market share in 2022, the U.K. is recognized as a lucrative market for cell therapy manufacturing. Support from regulatory bodies like the European Medicines Agency (EMA) ...
In January, the Abu Dhabi Stem Cells Centre reported promising results in treating Type 1 diabetes using umbilical cord-derived mesenchymal stem cell (UC-MSC) therapy. The Emirates Health Services ...
Brainstorm Cell Therapeutics is seeking FDA clearances to launch a Phase 3b clinical trial to test its NurOwn stem cell ...
Mitochondria play a crucial role in acquiring pluripotency and determining cell fate. The mitochondrial unfolded protein ...
10 天
Clinical Trials Arena on MSNDSMB recommends continuation of BioCardia’s cell therapy trial for heart failureAn independent Data Safety Monitoring Board (DSMB) has recommended the continuation of BioCardia's Phase I/II CardiALLO-HF ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果